Sahlgrenska University Hospital-Vastra Gotalandsregionen

At Sahlgrenska University Hospital-Vastra Gotalandsregionen in Gothenburg, clinical research in urology focuses strongly on prostate cancer and urothelial cancer, with studies also addressing biochemical recurrence after surgery and advanced disease. These trials are designed to improve treatment effectiveness, refine imaging-guided care, and support better long-term cancer control.

• Prostate cancer and biochemical recurrence after surgery
• Urothelial cancer and other genitourinary malignancies
• Testing treatment strategies that may improve survival and reduce recurrence

The site’s urology program reflects a broad interest in both localized and advanced genitourinary cancers, combining patient-centered care with research aimed at more precise and effective treatment choices.

A major part of the research portfolio at this hospital involves cancer studies across several therapeutic areas, including breast cancer, melanoma, lung cancer, pancreatic cancer, and colorectal cancer. The trials are largely focused on evaluating new therapies, comparing treatment combinations, and improving outcomes for patients with advanced or high-risk disease.

• Advanced solid tumors and metastatic cancer
• Breast, melanoma, lung, pancreatic, and colon cancers
• Assessing new immunotherapy and targeted treatment approaches

This oncology activity highlights a strong commitment to improving survival, disease control, and personalized treatment selection for people with a wide range of malignant tumors.

The site is also active in cardiovascular research, with studies in atrial fibrillation, heart failure, Takotsubo syndrome, and pulmonary arterial hypertension. Several trials aim to prevent stroke and systemic embolism, improve rhythm control, and evaluate treatments that may reduce hospitalizations and other serious complications.

• Atrial fibrillation and stroke prevention
• Heart failure and pulmonary arterial hypertension
• Testing therapies to improve cardiovascular outcomes and safety

These studies show a clear emphasis on both common and complex heart and vascular disorders, with research designed to support safer and more effective long-term management.

In the field of respiratory medicine, trials at this site include COPD, cystic fibrosis, and pulmonary fibrosis-related conditions. The research is aimed at easing symptoms, lowering exacerbation rates, and improving lung function and overall quality of life for people living with chronic respiratory illness.

• Chronic obstructive pulmonary disease and frequent exacerbations
• Cystic fibrosis and rare mutation-related disease
• Evaluating treatments that may improve breathing and disease stability

This work reflects ongoing efforts to advance care for chronic lung diseases through better symptom control and more durable treatment benefit.

Research in neurology and psychiatry includes studies in acute ischemic stroke, epilepsy, Parkinson’s disease, multiple sclerosis, and major depressive disorder. The main goals are to improve recovery after neurologic events, slow disease progression, and test new options for mood-related conditions, including cancer-related depression.

• Stroke recovery and stroke prevention
• Epilepsy, Parkinson’s disease, and multiple sclerosis
• Evaluating new treatments for neurologic and psychiatric conditions

This broad portfolio shows active investigation into both brain disorders and mental health, with a focus on practical improvements in daily functioning and long-term outcomes.

The site also conducts trials in immune-mediated diseases such as atopic dermatitis, Sjögren’s syndrome, and systemic sclerosis. These studies are intended to assess whether new therapies can better control inflammation, reduce symptoms, and improve patient comfort in chronic autoimmune and skin conditions.

• Atopic dermatitis and other inflammatory skin disease
• Sjögren’s syndrome and systemic sclerosis
• Testing therapies that may improve immune-related disease control

This area of research supports a wider effort to improve care for autoimmune disorders that can affect the skin, glands, and connective tissues.

Clinical trials in this area include studies of ectopic pregnancy, preeclampsia, and labour induction. The research is focused on improving maternal and pregnancy outcomes, while also exploring safer and more effective ways to manage common obstetric complications.

• Ectopic pregnancy and treatment options
• Preeclampsia and pregnancy prolongation strategies
• Evaluating safer approaches to labour induction

These studies show that the site contributes not only to urologic research but also to important women’s health questions in reproductive medicine.

The research portfolio includes studies in myelodysplastic syndrome, multiple myeloma, chronic lymphocytic leukemia, and lymphoma. These trials are generally aimed at improving disease control, reducing transfusion needs, and finding better treatment options for blood cancers and related disorders.

• Myelodysplastic syndrome and anemia management
• Multiple myeloma, lymphoma, and chronic lymphocytic leukemia
• Testing therapies to improve blood cancer outcomes and supportive care

This work adds another important dimension to the site’s broader oncology and hematology activity.